Creatinine-Cystatin C Discrepancy and Renal Transporter Polymorphisms in Japanese Patients with Breast Cancer Receiving Abemaciclib.

Watanabe H, Hirai K, Oba T, Ono M, Ito KI, Naito T

Open source

DOI
10.1002/cpt.70490
Published
2026 Sep 22
Container
Clinical pharmacology and therapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpt.70490,
  title = {Creatinine-Cystatin C Discrepancy and Renal Transporter Polymorphisms in Japanese Patients with Breast Cancer Receiving Abemaciclib.},
  author = {Watanabe H and Hirai K and Oba T and Ono M and Ito KI and Naito T},
  year = {2026},
  journal = {Clinical pharmacology and therapeutics},
  doi = {10.1002/cpt.70490},
  url = {https://doi.org/10.1002/cpt.70490}
}

RIS

TY  - JOUR
TI  - Creatinine-Cystatin C Discrepancy and Renal Transporter Polymorphisms in Japanese Patients with Breast Cancer Receiving Abemaciclib.
AU  - Watanabe H
AU  - Hirai K
AU  - Oba T
AU  - Ono M
AU  - Ito KI
AU  - Naito T
PY  - 2026
JO  - Clinical pharmacology and therapeutics
DO  - 10.1002/cpt.70490
UR  - https://doi.org/10.1002/cpt.70490
ER  - 

APA

H, W., K, H., T, O., M, O., KI, I., & T, N. (2026). Creatinine-Cystatin C Discrepancy and Renal Transporter Polymorphisms in Japanese Patients with Breast Cancer Receiving Abemaciclib.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.70490

Source records